[HTML] springer.com

[HTML][HTML] Emerging pharmacological therapies for ARDS: COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli, T Pham… - Intensive care …, 2020 - Springer
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …
被引用次数：74 相关文章

Emerging pharmacological therapies for ARDS: COVID-19 and beyond.

S Horie, B McNicholas, E Rezoagli… - Intensive Care …, 2020 - search.ebscohost.com
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS: COVID-19 and beyond.

S Horie, B McNicholas, E Rezoagli, T Pham, G Curley… - 2020 - cabidigitallibrary.org
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …
[HTML] nih.gov

[HTML][HTML] Emerging pharmacological therapies for ARDS: COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli, T Pham… - Intensive Care …, 2020 - ncbi.nlm.nih.gov
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli… - Intensive Care …, 2020 - research.monash.edu
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli, T Pham… - Intensive Care …, 2020 - pure.qub.ac.uk
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

H Shahd, MN Bairbre, R Emanuele, P Tài… - Intensive Care …, 2020 - search.proquest.com
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …
[PDF] researchgate.net

[PDF][PDF] Emerging pharmacological therapies for ARDS: COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli, T Pham, G Curley… - 2020 - researchgate.net
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS: COVID-19 and beyond

S Horie, B McNicholas, E Rezoagli… - Intensive care …, 2020 - pubmed.ncbi.nlm.nih.gov
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Emerging pharmacological therapies for ARDS: COVID-19 and beyond.

S Horie, B McNicholas, E Rezoagli, T Pham… - Intensive Care …, 2020 - europepmc.org
ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …